Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: the Chieti experience

被引：0
|
作者：
di Ioia, M. [1 ]
Travaglini, D. [1 ]
Di Tommaso, V. [1 ]
Mancinelli, L. [1 ]
Pietrolongo, E. [1 ]
De Luca, G. [1 ]
Farina, D. [1 ]
Lugaresi, A. [1 ]
机构：
[1] Univ G DAnnunzio, Neurosci Imaging & Clin Sci, Chieti, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1446
引用
收藏
页码：754 / 754
页数：1
相关论文
共 50 条
  • [1] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis
    Miller, Aaron E.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (02) : 181 - 194
  • [2] Teriflunomide: A Review in Relapsing-Remitting Multiple Sclerosis
    Scott, Lesley J.
    [J]. DRUGS, 2019, 79 (08) : 875 - 886
  • [3] The Danish experience of teriflunomide treatment in relapsing remitting multiple sclerosis
    Magyari, M.
    Buron, M.
    Illes, Z.
    Sellebjerg, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 472 - 472
  • [4] Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence
    Bayas, Antonios
    Maeurer, Mathias
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 265 - 274
  • [5] Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis
    Chan, Andrew
    de Seze, Jerome
    Comabella, Manuel
    [J]. CNS DRUGS, 2016, 30 (01) : 41 - 51
  • [6] Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
    Papadopoulou, Athina
    Kappos, Ludwig
    Sprenger, Till
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 749 - 759
  • [7] Efficacy and safety of first line oral therapies in relapsing-remitting multiple sclerosis: Dimethyl fumarate vs teriflunomide in the Chieti experience
    Di Tommaso, V.
    Mancinelli, L.
    di Ioia, M.
    Farina, D.
    Travaglini, D.
    Pietrolongo, E.
    De Luca, G.
    Lugaresi, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 870 - 871
  • [8] COST-EFFECTIVENESS OF TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Andreadou, E.
    Karageorgiou, K.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S339 - S339
  • [9] Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status
    Kallmann, Boris A.
    Ries, Stefan
    Kullmann, Jennifer S.
    Quint, Laura M.
    Engelmann, Ulrich
    Chan, Andrew
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [10] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
12345